Related Experiment Video
Updated: Aug 13, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 19, 2013
Serologic studies of the diagnosis and nosology of human leukemia
Abstract:
Nonhuman primate antisera to human leukemia-associated antigens and to normal T- and B-lymphocyte antigens are useful reagents for detecting and classifying leukemic cells in a microcytotoxicity assay. These antisera are able to distinguish lymphocytic from myeloid leukemia cells, and can also identify acute myelomonocytic leukemia and chronic myelocytic leukemia blastic crisis cells from cells of other types of leukemia. The advantages and disadvantages of the reagents in the nosology and clinical management of leukemia patients are discussed in depth. However, despite certain shortcomings in the microcytotoxicity assays, the reagents and method do provide the necessary tools for antigenic isolation and identification. Purified antigen may then serve to open new horizons in the detection, diagnosis, classification and perhaps therapy of human leukemia.
More Related Videos
08:00A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018